This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone Sep 2026 quarter: revenue Rs 6.75 lakh vs nil; net loss Rs 1.01 lakh vs Rs 48.33 lakh
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
By the next day the stock moved 3.5 pts less than Nifty Microcap 250 and 1.1 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone quarter ended 30 September 2026: revenue from operations was Rs 6.75 lakh against nil in the same quarter a year earlier; net loss Rs 1.01 lakh versus Rs 48.33 lakh. For the standalone half year ended 30 September 2026, revenue was Rs 12.40 lakh and net loss Rs 4.20 lakh, versus Rs 12.00 lakh and a Rs 41.27 lakh loss a year earlier. The review found no issues. Equity was negative Rs 226.00 lakh and borrowings were Rs 336.20 lakh.
Negative equity and Rs 336.20 lakh of borrowings raise financial risk; the smaller quarterly loss is encouraging but not a confirmed recovery.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹0.07 Cr | ₹0.00 Cr | turned positive |
| Operating profit | −₹0.04 Cr | −₹0.01 Cr | loss widened |
| Profit after tax | −₹0.01 Cr | −₹0.48 Cr | loss narrowed |
| EBITDA margin | -52.6% | — | — |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.